AC Immune SA (ACIU)
2.39
-0.03
(-1.24%)
USD |
NASDAQ |
May 03, 16:00
2.39
0.00 (0.00%)
After-Hours: 20:00
AC Immune Accounts Payable (Quarterly): 1.999M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.999M |
September 30, 2023 | 1.616M |
June 30, 2023 | 1.504M |
March 31, 2023 | 1.244M |
December 31, 2022 | 1.002M |
September 30, 2022 | 1.558M |
June 30, 2022 | 0.3531M |
March 31, 2022 | 0.5426M |
December 31, 2021 | 2.191M |
September 30, 2021 | 0.2301M |
June 30, 2021 | 0.3442M |
March 31, 2021 | 0.3928M |
December 31, 2020 | 2.500M |
September 30, 2020 | 1.109M |
June 30, 2020 | 1.516M |
March 31, 2020 | 0.7916M |
December 31, 2019 | 0.1466M |
Date | Value |
---|---|
September 30, 2019 | 0.00 |
June 30, 2019 | 0.1597M |
March 31, 2019 | 0.8326M |
December 31, 2018 | 2.010M |
September 30, 2018 | 0.5248M |
June 30, 2018 | 2.020M |
March 31, 2018 | 1.240M |
December 31, 2017 | 1.121M |
September 30, 2017 | 1.402M |
June 30, 2017 | 0.9984M |
March 31, 2017 | 2.640M |
December 31, 2016 | 3.965M |
September 30, 2016 | 2.931M |
June 30, 2016 | 2.679M |
March 31, 2016 | 1.03M |
December 31, 2015 | 1.739M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2019
2.500M
Maximum
Dec 2020
1.010M
Average
1.002M
Median
Dec 2022
Accounts Payable (Quarterly) Benchmarks
CRISPR Therapeutics AG | 38.15M |
Addex Therapeutics Ltd | 1.172M |
NLS Pharmaceutics Ltd | 3.113M |
Molecular Partners AG | 0.4881M |
MoonLake Immunotherapeutics | 0.5535M |